Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer. [electronic resource]
Producer: 20160505Description: 1099-106 p. digitalISSN:- 1556-1380
- Adult
- Aged
- Aged, 80 and over
- Clinical Trials as Topic -- methods
- Clinical Trials, Phase II as Topic -- methods
- Clinical Trials, Phase III as Topic -- methods
- Disease-Free Survival
- Endpoint Determination
- Female
- Humans
- Lung Neoplasms -- mortality
- Male
- Middle Aged
- Randomized Controlled Trials as Topic -- methods
- Small Cell Lung Carcinoma -- mortality
- Survival Analysis
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.